George Elston's Net Worth

$1.84 Million

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is George Elston?

George Elston has an estimated net worth of $1.84 Million. This is based on reported shares across multiple companies, which include AVANT IMMUNOTHERAPEUTICS INC, EyePoint Pharmaceuticals, Inc., and COLUMBIA LABORATORIES INC.

SEC CIK

George Elston's CIK is 0001429932

Past Insider Trading and Trends

2023 was George Elston's most active year for acquiring shares with 7 total transactions. George Elston's most active month to acquire stocks was the month of May. 2024 was George Elston's most active year for disposing of shares, totalling 8 transactions. George Elston's most active month to dispose stocks was the month of January. 2019 saw George Elston paying a total of $14,290.00 for 755,000 shares, this is the most they've acquired in one year. In 2024 George Elston cashed out on 45,315 shares for a total of $232,591.32, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVANT IMMUNOTHERAPEUTICS INC (CLDX) Snapshot price: $44

Investor

George Elston owns 28,500 units of Common Stock which is worth $1,254,000.00. In the year 2008 George Elston filed a total of 10 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+54.05%
10K
—
—
28.5K
Jun 8
Form 4
+54.17%
6.5K
—
—
18.5K
Jun 10
Form 4
+20.00%
2K
—
—
12K
Jun 4
Form 4
+25.00%
2K
—
—
10K
Jun 19
Form 4
+33.33%
2K
—
—
8K
Jun 20
Form 4
∞
2K
—
—
2K
Jun 22
Form 4
∞
2K
—
—
2K
Sep 22
Form 4
∞
2K
—
—
2K
Dec 23
Form 4
—
0
—
—
0
Sep 25
Form 3
—
0
—
—
0
No matching records found

EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97

Chief Financial Officer

George Elston owns 47,480 units of Common Stock which is worth $378,415.60. From 2019 to 2024 George Elston acquired a total of 89,351 shares in EyePoint Pharmaceuticals, Inc. at a cost of $34,802.00, George also disposed a total of 13,451 shares of EyePoint Pharmaceuticals, Inc. equalling to $250,025.05.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.88%
3.87K
$11.16
-$40,477.32
47.48K
May 25
Form 4
+21.13%
7.61K
$28.80
-$91,929.60
43.61K
Feb 9
Form 4
+41.61%
10.37K
$20.40
-$100,184.40
35.31K
Jan 5 - Jan 6
Form 4
—
0
—
—
0
Oct 16
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
May 25
Form 4
+87.69%
10.8K
—
—
23.12K
Feb 9
Form 4
—
0
—
—
0
Jan 6
Form 4
+51.05%
3.25K
$10.13
-$17,433.73
9.6K
Feb 9
Form 4
—
0
—
—
0
Jun 22
Form 4
+33.33%
10K
$0.48
$4,800.00
40K
Sep 4
Form 4
+50.00%
10K
$0.61
$6,112.00
30K
Aug 24
Form 4
+100.00%
10K
$0.96
$9,600.00
20K
Mar 12
Form 4
—
0
—
—
0
Feb 28
Form 4
∞
10K
$1.43
$14,290.00
10K
Nov 14 - Nov 15
Form 3
—
0
—
—
0
No matching records found

COLUMBIA LABORATORIES INC No price found

Chief Financial Officer

George Elston owns 1,000 units of common stock, par value $0.01. In the year 2014 George Elston filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1K
$5.50
$5,500.00
1K
Aug 31
Form 4
—
0
—
—
0
Feb 19
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Oct 1
No matching records found